Heart Disease News and Research

Latest Heart Disease News and Research

Apitope-led consortium awarded FP7 Health Innovation funding to develop Graves' disease vaccine

Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces that the consortium, led by Apitope, which includes GSK Vaccines, Quintiles and KWS Biotest Limited, has been awarded prestigious Framework Programme 7 Health Innovation funding by the European Commission to develop its Graves' disease therapeutic vaccine, including a Phase I first-in-man study in Graves' disease patients.

8 Jan 2014

StemGenex offers stem cell treatment studies to patients diagnosed with diabetes, neurological diseases

According to The American Diabetes Association there are over 25 million people in the US living with diabetes. These patients are suffering from complications such as heart disease, stroke, high blood pressure, blindness, kidney disease, neuropathy and amputation.

8 Jan 2014

New study finds that Americans had more health concerns during the recession

We ring in the New Year with hopes of being healthy, wealthy, and wise. A new study led by San Diego State University School of Public Health research professor John W. Ayers suggests that from a public health standpoint, health and wealth may be connected.

8 Jan 2014

Analog Devices unveils high-precision meter-on-a-chip for different portable health applications

Analog Devices, Inc. unveiled today a high-precision, low-power meter-on-a-chip for a range of portable health applications such as point-of-care diagnostics, home/self-test health devices, and wearable vital signs monitors, including those for sports and fitness.

8 Jan 2014

Qardio launches revolutionary blood pressure monitor at 2014 CES show

Qardio, a technology company dedicated to transforming the way we manage our heart health and track our wellness, is formally announcing the launch of the QardioArm at the 2014 CES show. QardioArm is a revolutionary blood pressure monitor.

8 Jan 2014

Hospitals with higher rates of readmissions may suffer cut in Medicare payments by 2015

Hospitals that treat more poor seniors who are on both Medicaid and Medicare tend to have higher rates of readmissions, triggering costly penalties from the Centers for Medicare and Medicaid Services, finds a new study in Health Services Research.

8 Jan 2014

Study links racism-related factors and biological aging among African American men

A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.

8 Jan 2014

A&D Medical to partner with Salutron to expand Wellness Connected platform

In a strategic business decision to provide its customers with an optimized connected health experience, A&D Medical, a global manufacturer of precision measurement solutions for the healthcare industry, announced today it will partner with Salutron, the industry leader in wearable activity monitoring technology with heart rate. With this alliance, A&D Medical will include Salutron's LifeTrak family of Bluetooth Smart activity monitors as a core component of its new Wellness Connected Platform and device suite.

8 Jan 2014

Research opens door to new direction of PAH treatment

The development of new, more effective vasodilators to treat pulmonary arterial hypertension has been hampered because of their systemic toxicity and adverse side effects. An international team of investigators seeking to surmount these problems and increase drug efficacy have determined that a vascular homing peptide can selectively target hypertensive pulmonary arteries to boost the pulmonary but not systemic effects of vasodilators. Importantly for potential clinical use, this peptide retains its activity when given sublingually. The results using a rat model of PAH are published in the American Journal of Pathology.

8 Jan 2014

Daiichi Sankyo submits Marketing Authorization Application for edoxaban to EMA

Daiichi Sankyo, Company Limited (hereafter, Daiichi Sankyo) today announced that the Marketing Authorization Application for its investigational, oral, once-daily direct factor Xa-inhibitor edoxaban has been submitted to the European Medicines Agency.

7 Jan 2014

Aggression treatment needed for patients with bipolar disorder

Patients with bipolar disorder are at increased risk for aggression, particularly when acutely ill, show results from a longitudinal study.

7 Jan 2014

Elderly people with high serum vitamin E levels less likely to suffer from memory disorders

Elderly people with high serum vitamin E levels are less likely to suffer from memory disorders than their peers with lower levels, according to a study published recently in Experimental Gerontology.

7 Jan 2014

Crowdsourcing fungal metabolites with antitumor activity: an interview with Dr. Robert H. Cichewicz, University of Oklahoma

Fungi have played a large role in the development of many important drugs that are in wide use today. The most well-known of these are the penicillins.

7 Jan 2014

Barostim Therapy: A cost-effective treatment for patients with drug resistant hypertension

CVRx, Inc., a privately held medical device company, today announced findings from a health-economic analysis published in the Journal of Hypertension that indicates Barostim Therapy is a cost-effective treatment option for patients with drug resistant hypertension.

7 Jan 2014

FDA OOPD grants orphan drug designation to Alitair's Erdosteine for treatment of bronchiectasis

Alitair Pharmaceuticals, Inc., today announced that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for its drug candidate, Erdosteine, for the treatment of bronchiectasis. Erdosteine is a mucolytic with antibacterial, anti-inflammatory, and antioxidant properties.

7 Jan 2014

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Commission has granted approval for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas, or metastatic pancreatic cancer.

7 Jan 2014

Ihealth unveils new wearable personal health devices at CES 2014

Today, iHealth Lab Inc., announced the extension of its suite of personal mobile health devices to include a line of wearable products designed to provide monitoring over an extended period of time.

7 Jan 2014

Oxygen Biotherapeutics announces publication of Phase 3 trial protocol for levosimendan

Oxygen Biotherapeutics, Inc. ("OBI") a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the protocol of their phase 3 trial for levosimendan has been published on ClinicalTrials.gov, "Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Heart Surgery on Cardiopulmonary Bypass."

7 Jan 2014

Study: Long-term weight loss maintenance possible if individuals adhere to key health behaviors

Researchers from The Miriam Hospital have published one of the first studies of its kind to follow weight loss maintenance for individuals over a 10-year period. The results show that long-term weight loss maintenance is possible if individuals adhere to key health behaviors. The study is published in the January 2014 issue of the American Journal of Preventive Medicine.

7 Jan 2014

Adocia initiates phase IIa clinical trial of BioChaperone Lispro formulation

Adocia, a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).

7 Jan 2014

Heart Disease News and Research

Latest Heart Disease News and Research

Apitope-led consortium awarded FP7 Health Innovation funding to develop Graves' disease vaccine

StemGenex offers stem cell treatment studies to patients diagnosed with diabetes, neurological diseases

New study finds that Americans had more health concerns during the recession

Analog Devices unveils high-precision meter-on-a-chip for different portable health applications

Qardio launches revolutionary blood pressure monitor at 2014 CES show

Hospitals with higher rates of readmissions may suffer cut in Medicare payments by 2015

Study links racism-related factors and biological aging among African American men

A&D Medical to partner with Salutron to expand Wellness Connected platform

Research opens door to new direction of PAH treatment

Daiichi Sankyo submits Marketing Authorization Application for edoxaban to EMA

Aggression treatment needed for patients with bipolar disorder

Elderly people with high serum vitamin E levels less likely to suffer from memory disorders

Crowdsourcing fungal metabolites with antitumor activity: an interview with Dr. Robert H. Cichewicz, University of Oklahoma

Barostim Therapy: A cost-effective treatment for patients with drug resistant hypertension

FDA OOPD grants orphan drug designation to Alitair's Erdosteine for treatment of bronchiectasis

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

Ihealth unveils new wearable personal health devices at CES 2014

Oxygen Biotherapeutics announces publication of Phase 3 trial protocol for levosimendan

Study: Long-term weight loss maintenance possible if individuals adhere to key health behaviors

Adocia initiates phase IIa clinical trial of BioChaperone Lispro formulation

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Heart Disease News and Research

Latest Heart Disease News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in